Sort
10,766 grants matching “checkpoint inhibitor”
Brain Tumor Clinical and Clinical Research Program
$2,237,606Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
Molecular Pathogenesis of Neoplasia
$2,235,363Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
$2,229,253Haian Fu · Emory University · P01 · FY2022 · CA
Human Artificial Chromosomes for Cancer Research and Functional Genomics
$2,227,197Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,225,217Barbara Burtness · Yale University · P50 · FY2023 · DE
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,219,566Barbara Burtness · Yale University · P50 · FY2022 · DE
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$2,219,279Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Brain Tumor Clinical and Clinical Research Program
$2,214,994Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
$2,214,926Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2016 · CA
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,211,341Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,210,645Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2022 · CA
SPORE: Targeted Therapies for Glioma
$2,207,927Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$2,207,796Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,206,679Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease
$2,205,213Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · P01 · FY2025 · AI
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,203,749Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,197,848Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
$2,197,314Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
Mayo Clinic Breast Cancer SPORE
$2,194,603James Newell Ingle · Mayo Clinic Rochester · P50 · FY2006 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$2,194,470Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SPORE in Skin Cancer
$2,194,229Meenhard Herlyn · Wistar Institute · P50 · FY2022 · CA
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,189,154David A Barbie · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Targeting Lung Cancer Vulnerabilities
$2,188,505John D Minna · Ut Southwestern Medical Center · P50 · FY2024 · CA
SPORE in Skin Cancer
$2,186,705Meenhard Herlyn · Wistar Institute · P50 · FY2023 · CA
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
$2,185,934Dawn E Quelle · University Of Iowa · P50 · FY2025 · CA